PZI
- Product code
- PZI
- Device name
- Prescription Use Blood Glucose Meter For Near-Patient Testing
- Device class
- Class 2
- 21 CFR
- 21 CFR 862.1345
- Medical specialty
- Clinical Chemistry
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 4
- Summaries archived here
- 3 (direct download)
- 510(k) clearances (all years, FDA)
- 14 (all years; only the last 3 years are listed here)
FDA classification definition
Intended for use in near-patient testing settings for in vitro diagnostic, multiple-patient use for the quantitative determination of glucose throughout all hospital and all professional healthcare settings for use in determining dysglycemia.
510(k) clearances, last 3 years (4)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K252323 | 2026-06-12 | Roche Diagnostics | cobas pulse blood glucose monitoring system | |
| K221349 | 2024-11-19 | Taidoc Technology Corporation | XPER Technology PREMIUM Pro Blood Glucose Monitoring… | |
| K220272 | 2024-04-26 | Roche Diagnostics | cobas pulse blood glucose monitoring system | FDA |
| K232075 | 2024-02-23 | Nova Biomedical Corporation | StatStrip Glucose Hospital Meter System |
Official FDA classification page: PZI
Classification and pathway per current FDA publications. Data from openFDA (CC0).